TrialCancer science2016

Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy.

Toyoaki Hida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.